Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.650
+0.033 (5.35%)
Nov 21, 2024, 12:53 PM EST - Market open
Virpax Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -13.24 | -15.19 | -21.65 | -12.06 | -4.34 | -3.31 | |
| Stock-Based Compensation | 0.12 | 0.54 | 0.75 | 0.97 | 1.48 | 1.12 | |
| Other Operating Activities | - | - | - | -0.06 | 0.15 | 0.12 | |
| Change in Accounts Payable | 0.82 | 0.6 | -0.99 | -0.69 | 1.34 | 0.92 | |
| Change in Other Net Operating Assets | -4.56 | 4.19 | 4.05 | -2.71 | -0.01 | 0.01 | |
| Operating Cash Flow | -16.85 | -9.85 | -17.85 | -14.54 | -1.38 | -1.13 | |
| Long-Term Debt Issued | - | - | - | 0.1 | 0.07 | 0.5 | |
| Long-Term Debt Repaid | - | - | - | -1.6 | - | - | |
| Net Debt Issued (Repaid) | - | - | - | -1.5 | 0.07 | 0.5 | |
| Issuance of Common Stock | 5.02 | - | - | 58.02 | 1.38 | 0.63 | |
| Other Financing Activities | -0.3 | - | - | -5.19 | -0.05 | - | |
| Financing Cash Flow | 4.72 | - | - | 51.33 | 1.4 | 1.13 | |
| Net Cash Flow | -12.14 | -9.85 | -17.85 | 36.79 | 0.01 | -0.01 | |
| Free Cash Flow | -16.85 | -9.85 | -17.85 | -14.54 | -1.38 | -1.13 | |
| Free Cash Flow Per Share | -7.53 | -8.41 | -15.24 | -21.78 | -4.46 | -3.86 | |
| Cash Interest Paid | - | - | - | 0.36 | - | - | |
| Levered Free Cash Flow | -9.51 | -2.75 | -7.66 | -10.34 | 0.35 | -0.62 | |
| Unlevered Free Cash Flow | -9.44 | -2.75 | -7.66 | -10.28 | 0.44 | -0.54 | |
| Change in Net Working Capital | 3.58 | -4.79 | -3.06 | 3.74 | -1.59 | -0.77 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.